Elizabeth Buck
Cincinnati Children's Hospital Medical Center(US)Duke Medical Center(US)
Publications by Year
Research Areas
Growth Hormone and Insulin-like Growth Factors, Metabolism, Diabetes, and Cancer, HER2/EGFR in Cancer Research, Cancer Risks and Factors, Lung Cancer Treatments and Mutations
Most-Cited Works
- → Epithelial to Mesenchymal Transition Is a Determinant of Sensitivity of Non–Small-Cell Lung Carcinoma Cell Lines and Xenografts to Epidermal Growth Factor Receptor Inhibition(2005)672 cited
- → Discovery of OSI-906: A Selective and Orally Efficacious Dual Inhibitor of the IGF-1 Receptor and Insulin Receptor(2009)307 cited
- → Ullmann Diaryl Ether Synthesis: Rate Acceleration by 2,2,6,6-Tetramethylheptane-3,5-dione(2002)294 cited
- → Rapamycin synergizes with the epidermal growth factor receptor inhibitor erlotinib in non–small-cell lung, pancreatic, colon, and breast tumors(2006)233 cited
- → Compensatory Insulin Receptor (IR) Activation on Inhibition of Insulin-Like Growth Factor-1 Receptor (IGF-1R): Rationale for Cotargeting IGF-1R and IR in Cancer(2010)216 cited
- → Feedback Mechanisms Promote Cooperativity for Small Molecule Inhibitors of Epidermal and Insulin-Like Growth Factor Receptors(2008)209 cited